{{Rsnum
|rsid=398652
|Chromosome=14
|position=56058851
|Orientation=plus
|GMAF=0.3517
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 20.5 | 77.7
| HCB | 40.1 | 46.0 | 13.9
| JPT | 44.2 | 41.6 | 14.2
| YRI | 17.7 | 46.9 | 35.4
| ASW | 18.2 | 45.5 | 36.4
| CHB | 40.1 | 46.0 | 13.9
| CHD | 37.6 | 55.0 | 7.3
| GIH | 5.9 | 40.6 | 53.5
| LWK | 15.5 | 36.4 | 48.2
| MEX | 17.5 | 43.9 | 38.6
| MKK | 2.6 | 23.1 | 74.4
| TSI | 1.0 | 22.5 | 76.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21460395
|Trait=None
|Title=A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer
|RiskAllele=
|Pval=0.000002
|OR=0.1200
|ORtxt=[NR] unit increase
|OA=1
}}

{{PMID Auto
|PMID=23180556
|Title=Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinoma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}